EBMT 2024 | The collaboration of the EBMT and ISCT for the development and monitoring of ATMPs and SoHo
Nina Worel, MD, Medical University of Vienna, Vienna, Austria, discusses the collaboration of the European Society for Blood and Marrow Transplantation (EBMT) and the International Society for Cell & Gene Therapy (ISCT) to improve access to and regulation of advanced therapy medicinal products (ATMPs) and substances of human origin (SoHo) intended for human application. The EBMT patient registry has outcome data following hematopoietic stem cell transplantation (HSCT) and CAR-T treatment, which can be used for post-authorization safety and efficacy studies. Prof. Worel also mentions the GoCART Coalition, which is an initiative to enhance training for healthcare professionals (HCPs). This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research grants: Sanofi Genzyme, Therakos Malinckrodt
Advisory Boards: BMS Celgene, Kite Gilead, Novartis, Sanofi Genzyme
Speaker’s fees: Kite Gilead, Novartis, Pierre Fabre, Sanofi Genzyme, Therakos Malinckrodt
Travel Support: BMS Celgene, Kite Gilead, Novartis, Pierre Fabre, Sanofi Genzyme
